What You Should Know:
Weave, a leading all-in-one experience platform for small and medium-sized healthcare practices, today announces the addition of AI-driven voicemail transcriptions to its Phones offering.Now available to Weave’s 27,000+ customers, Voicemail Transcription will enhance Weave Phones by automatically transcribing voicemails from patients, allowing for efficient, visible, and private reading experiences of voicemails. With this update, users will now see the voicemail
Read More
3 in 4 Patients Don’t Trust AI in Healthcare Setting
What You Should Know:
Carta Healthcare®, a company whose mission is to improve patient care by harnessing the value of clinical data, today announced the results of a survey measuring American perception and trust of artificial intelligence (AI) in healthcare.Propeller Insights conducted an online survey of 1,027 U.S. consumers between August 18 and August 29, 2023.
Evolving Public Perception of the Role of AI in Healthcare – Key Insights
The survey finds that on average,
Read More
Penn Medicine Taps Flatiron Health for Advanced Cancer Care
What You Should Know:
Flatiron Health today announced a new agreement to bring Flatiron Assist™ advanced cancer care insights to oncology care clinicians at Penn Medicine’s Abramson Cancer Center (ACC).The collaboration between Flatiron Health and Penn Medicine will focus on further enabling clinicians at ACC to determine and promote site-preferred pathways and open clinical trials at the point of care alongside the NCCN Clinical Practice Guidelines in Oncology (NCCN
Read More
Cedars-Sinai Uses AI to Identify People With Abnormal Heart Rhythms
What You Should Know:
Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence (AI) algorithm can detect an abnormal heart rhythm in people not yet showing symptoms.The algorithm, which identified hidden signals in common medical diagnostic testing, may help doctors better prevent strokes and other cardiovascular complications in people with atrial fibrillation-the most common type of heart rhythm disorder.
AI-Driven Algorithm to Detect
Read More
Pangea, FibroFighters Partner to Advance Rare Liver Cancer Treatment
What You Should Know:
Pangea Biomed, the startup behind the innovative treatment response predictor, ENLIGHT, today announced its partnership with patient-centric advocacy organization FibroFighters to advance treatment for fibrolamellar carcinoma (FLC) patients.Fibrolamellar carcinoma (FLC) is a rare liver cancer that typically presents in young adolescents and young adults at a median age of 22 who have no history of liver disease. There is no clear standard of care for the disease, and in
Read More
Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients
What You Should Know:
Today, Nucleus RadioPharma the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals has announced an oversubscribed $56 million Series A funding round led by Eclipse and GE HealthCare with participation from Echo Global, Fox Chase Cancer Center, Granger Management, Mayo Clinic, Mercy Health, and University of Missouri.With this round of funding,
Read More
Pair Team Secures $9M to Connect Underserved Communities to Care
What You Should Know:
Pair Team, a virtual and community-based primary care solution connecting Medicaid's highest-risk patients to high-quality care, today announced it has raised $9 million in Series A funding. The financing was led by NEXT VENTURES, with participation from PTX Capital, Kapor Capital, Kleiner Perkins, Y Combinator, and several notable healthcare angel investors including Jay Desai.The funding will be used to help Pair Team accelerate its
Read More
PathAI Diagnostics Unveils AI-Assisted Lab Test for MASLD and MASH
What You Should Know:
PathAI Diagnostics, formerly Poplar Healthcare, a leading laboratory services company, today unveiled the world’s first AI-assisted laboratory-developed test for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).MASLD and MASH are posing an escalating healthcare challenge, affecting millions of individuals worldwide – as many as 37.8% of the global adult population suffers from some form of MASLD,
Read More
Gero Raises $6M for Physics-Powered GenAI Biotech
What You Should Know:
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round.This funding round positions Gero to continue internal drug development programs, grow its scientific team to boost platform technology development, and expand its US presence. The round was led by Melnichek Investments, a Cyprus-based VC firm that seeks to improve the quality of human lives by funding and supporting promising, potentially high-impact,
Read More
Curana Health, Innovaccer Partner to Accelerate Value-Based Care for Seniors
What You Should Know:
Today Innovaccer Inc. announced that Curana Health, an innovative, fast-growing healthcare organization on a mission to improve the health, happiness, and dignity of senior living residents, is expanding its partnership with Innovaccer to meet strong market demand for its services, and to support the expansion of its value-based programs for high-risk populations nationwide.Last year Innovaccer announced that Curana Health had
Read More
